Table 3.
Comparison of miRNAs levels and gender, the primary tumor (T) and regional lymph nodes (N).
| PTC (Copies/µL) | |||||
| Variability | Let-7a | Let-7c | Let-7d | Let-7f | Let-7i |
| Gender | |||||
| Male | 38 ± 17 (37) | 32 ± 27(20) | 10 ± 7 (9) | 13 ± 7 (10) | 48 ± 27 (44) |
| Female | 245 ± 817 (72) | 107 ± 119 (53) | 63 ± 167 (19) | 71 ± 194 (21) | 230 ± 507 (72) |
| T&N staging | |||||
| T1 + T2 | 121 ± 150 (65) | 93 ± 106 (51) | 39 ± 52 (16) | 42 ± 47 (20) | 160 ± 222 (67) |
| T3 + T4 | 543 ± 1 551 (50) | 119 ± 143 (69) | 115 ± 311 (13) | 134 ± 367 (16) | 372 ± 905 (83) |
| N0 | 119 ± 130 (72) | 110 ± 114 (67) | 38 ± 45 (19) | 41 ± 43 (21) | 183 ± 240 (90) |
| N1 | 555 ± 1 484 (53) | 116 ± 142 (45) | 123 ± 300 (9) | 137 ± 352 (11) | 367 ± 869 (76) |
| NX | 54 ± 59 (25) | 36 ± 24 (36) | 20 ± 22 (12) | 31 ± 33 (16) | 60 ± 79 (33) |
| Control(Copies/µL) | |||||
| Let-7a | Let-7c | Let-7d | Let-7f | Let-7i | |
| Gender | |||||
| Male | 30 ± 28 (25) | 18 ± 13 (21) | 5 ± 4 (5) | 11 ± 10 (10) | 30 ± 22 (32) |
| Female | 73 ± 86 (33) | 53 ± 58 (20) | 24 ± 31 (7) | 24 ± 29(10) | 81 ± 77 (61) |
Data are expressed as mean ± standard deviation (median).